Industry Insight
Discovery Technology
Analytical Laboratory Technology
Biopharma
Manufacturing
Delivery Systems
Ingredients, Formulation and Finishing
Bioprocessing
View our other publications with free access to extensive archives
  To print this article:
Existing subscribers please log in:
 
  USER NAME  
  PASSWORD  
   Or select

Or become a subscriber
 
 
 

Trends in Pharmaceutical Deal-Making

The downturn in economies as a result of the credit crunch has had a marked impact on the pharmaceutical industry. Fewer deals are being made and even cash-rich companies are being more careful with their investments. When they choose to engage in risk-sharing deals however, they are ready to pay more, in turn creating a polarised biotechnology sector with a shakeout of less attractive innovation.

Tibor Papp at PharmaVentures Ltd (June 2010)

Keywords: Downturn, Biotechnology Sector, Deal activity, TRENDS IN COLLABORATIVE DEAL-MAKING, THE IPO MARKET

    View full article    |    Back to Industry Insight section




Advair,Flovent,VentolinSymbicort,Serevent,FlonaseAstelin Rhinocort
IPTonline © 2004 The Pharmaceutical Technology Journal | Terms and Conditions | info@iptonline.com | UK Contacts |
Providing a platform of communication on new ideas, developments and innovations | UK Tel No. +44 20 77243456 | Back to top of page |